Related Experiment Video
Updated: Dec 21, 2025

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
Published on: October 18, 2011
Abstract:
Findings from a subgroup of the TAILORx trial on early breast cancer reveal that endocrine therapy can contribute to extended cognitive decline, whether or not women receive initial chemotherapy. The results suggest that women taking hormone therapy should be periodically assessed for worsening cognitive symptoms over the course of treatment.
More Related Videos
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
05:32Author Spotlight: Investigating the Relationship Between FSH and Pathophysiological Changes in Perimenopausal Women - Insights from a Mouse Model
Published on: August 11, 2023
Related Concept Videos
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Alzheimer's Disease: Treatment
Cognitive Development During Adulthood
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Psychoneuroimmunology: Diabetes and Cancer
Drug Dosing: Geriatric Patients